{
    "clinical_study": {
        "@rank": "68697", 
        "arm_group": {
            "arm_group_label": "Stem cells implantation", 
            "arm_group_type": "Active Comparator", 
            "description": "Patients with severe coronary artery disease with ischemic cardiomyopathy managed with concomitant coronary artery bypass grafting and intramyocardial administration of allogeneic mensenchymal stem cells."
        }, 
        "brief_summary": {
            "textblock": "The aim of the present study is to investigate safety and efficacy of intramyocardial\n      implantation of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy\n      at the time of coronary artery bypass grafting."
        }, 
        "brief_title": "Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting in Patients With Ischemic Cardiomyopathy", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Coronary Artery Disease", 
            "Ischemic Cardiomyopathy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Ischemia", 
                "Cardiomyopathies"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age from 18 to 75 years\n\n          -  Severe coronary artery disease amenable to surgical revascularization according to\n             current guidelines\n\n          -  History of acute myocardial infarction at least 14 days previously\n\n          -  Left ventricular ejection fraction (LVEF) \u2264 40% as assessed with echocardiography\n\n          -  Distinct area of dyskinetic or akinetic left ventricular myocardium corresponding\n             with the infarct localization\n\n          -  Patient's informed consent obtained\n\n        Exclusion Criteria:\n\n          -  Emergency operation\n\n          -  Debilitating chronic disease (eg. malignancy or terminal renal failure)\n\n          -  Concomitant valve surgery\n\n          -  Previous cardiac surgery\n\n          -  Malignant ventricular arrhythmias\n\n          -  Haematologic disease\n\n          -  Woman in reproductive age\n\n          -  Severe psychiatric illness"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01753440", 
            "org_study_id": "AHEPA_CTL_01"
        }, 
        "intervention": {
            "arm_group_label": "Stem cells implantation", 
            "description": "Intramyocardial implantation of allogeneic mesenchymal stem cells", 
            "intervention_name": "Intramyocardial implantation of allogeneic mesenchymal stem cells", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "coronary artery disease", 
            "heart failure", 
            "stem cells implantation"
        ], 
        "lastchanged_date": "November 27, 2013", 
        "location": {
            "contact": {
                "email": "antonits@auth.gr", 
                "last_name": "Polychronis Antonitsis, MD, DSc", 
                "phone": "+ 30 2310 994871"
            }, 
            "facility": {
                "address": {
                    "city": "Thessaloniki", 
                    "country": "Greece", 
                    "zip": "546 36"
                }, 
                "name": "AHEPA University Hospital"
            }, 
            "investigator": {
                "last_name": "Polychronis Antonitsis, MD, DSc", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Greece"
        }, 
        "number_of_arms": "1", 
        "official_title": "Study on the Safety and Efficacy of Allogeneic Mesenchymal Stem Cell Implantation Combined With Bypass Grafting in Patients With Coronary Artery Disease and Ischemic Cardiomyopathy.", 
        "overall_contact": {
            "email": "antonits@auth.gr", 
            "last_name": "Polychronis Antonitsis, MD, DSc", 
            "phone": "+ 30 2310994871"
        }, 
        "overall_official": {
            "affiliation": "AHEPA University Hospital", 
            "last_name": "Kyriakos Anastasiadis, MD, DSc, FETCS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Greece: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Change in left ventricular ejection fraction assesed with echocardiography after intramyocardial implantation of allogeneic mesenchymal stem cells.", 
                "measure": "Left ventricular ejection fraction", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "description": "change in segmental perfusion as assesed with SPECT after intramyocardial implantation of allogeneic mesenchymal stem cells.", 
                "measure": "Myocardial segmental perfusion", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }
        ], 
        "reference": [
            {
                "PMID": "23117550", 
                "citation": "Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW. Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012 Dec 12;308(22):2369-79."
            }, 
            {
                "PMID": "21852003", 
                "citation": "Anastasiadis K, Antonitsis P, Doumas A, Koliakos G, Argiriadou H, Vaitsopoulou C, Tossios P, Papakonstantinou C, Westaby S. Stem cells transplantation combined with long-term mechanical circulatory support enhances myocardial viability in end-stage ischemic cardiomyopathy. Int J Cardiol. 2012 Mar 22;155(3):e51-3. doi: 10.1016/j.ijcard.2011.07.062. Epub 2011 Aug 17."
            }, 
            {
                "PMID": "20600097", 
                "citation": "Menasche P. Cardiac cell therapy: lessons from clinical trials. J Mol Cell Cardiol. 2011 Feb;50(2):258-65. doi: 10.1016/j.yjmcc.2010.06.010. Epub 2010 Jun 30. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01753440"
        }, 
        "responsible_party": {
            "investigator_affiliation": "AHEPA University Hospital", 
            "investigator_full_name": "Kyriakos Anastasiadis", 
            "investigator_title": "Associate Professor Kyriakos Anastasiadis", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "all-cause mortality", 
                "safety_issue": "Yes", 
                "time_frame": "one year"
            }, 
            {
                "measure": "all-cause morbidity", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "measure": "major adverse cardiac and cerebrovascular events", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }
        ], 
        "source": "AHEPA University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AHEPA University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}